GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncologix Tech OCLG · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

+9900.00%

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Oncologix Tech

Its shares trade under the ticker OCLG. It has been listed since 11 February 1987. In the fiscal year to 31 August 2017, it reported revenue of $2.9m and a net loss of $2.4m. At that date it held total assets of $1.5m and shareholders' equity of −$6.0m.

Oncologix Tech, Inc. is a medical holding company, which is engaged in the operation and manufacture of medical device products. The company is headquartered in Kentwood, Michigan. The firm has been engaging manufacturers and stakeholders in the industry both in the United States and South Korea to execute agreements with partners, customers, vendors, and manufacturers, reviewing licenses and sublicense agreements with potential licensors, interviewing and hiring employees, and conducting research and due diligence on potential partners, joint-ventures, and acquisitions in the biotech industry. The firm is also seeking additional acquisitions of diagnostic and biotechnology opportunities.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
11 Feb 1987

Leadership

Pay as last reported

  • Mr. Michael KramarzChairman of the Board, Chief Executive Officer, Chief Financial Officer, since 2004$80,066
  • Mr. Roy ErwinPresident, since 2013$58,750
  • Ms. Vickie HartPresident of Amian Angels, Inc.
  • Mr. Harold HalmanChief Operating Officer, Director, since 2014

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Oncologix Tech Inc operates in the Health Care sector with a focus on medical device manufacturing.
  • The company has established partnerships in the US and South Korea for device production and research.
  • Oncologix Tech actively seeks acquisitions in diagnostic and biotechnology sectors.

Weaknesses

  • The company's headquarters in Kentwood, Michigan, may limit access to major biotech hubs.
  • Oncologix Tech has not yet secured major manufacturing agreements in key markets.
  • Limited information on current product lines and market share is available.

Opportunities

  • Expanding partnerships in South Korea could enhance medical device manufacturing capabilities.
  • Acquiring diagnostic and biotechnology firms presents growth potential in the Health Care sector.
  • The US market offers opportunities for new medical device product launches.

Threats

  • Competition from established biotech firms in the US and South Korea poses a risk.
  • Regulatory changes in the Health Care industry could impact operations.
  • Economic downturns may reduce investment in medical device manufacturing.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.